Dra. Ana María Estrada Sánchez

Investigadora Titular "A"

Integrante del SNI. Nivel 2

División de Biología Molecular

ana.estrada@ipicyt.edu.mx

Selección de artículos de investigación

Publicaciones en el Science Citation Index

1.- Estrada-Sánchez AM, Rangel-Barajas C, Howe AG, Barton SJ, Mach RH, Luedtke RR, Rebec GV. "Selective Activation of D3 Dopamine Receptors Ameliorates DOI-Induced Head Twitching Accompanied by Changes in Corticostriatal Processing". INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 2023;

2.- Niño SA, Chi-Ahumada E, Carrizales L, Estrada-Sánchez AM, Gonzalez-Billault C, Zarazúa S, Concha L, Jiménez-Capdeville ME. "Life-long arsenic exposure damages the microstructure of the rat hippocampus.". BRAIN RESEARCH . 2022;

1775 : 147742 Número de citas: 1

3.- Donzis EJ*, Estrada-Sánchez AM*, Indersmitten T, Oikonomou K, Tran CH, Wang C, Latifi S, Golshani P, Cepeda C, Levine MS. * Primer autor. "Cortical Network Dynamics is Altered in Mouse Models of Huntington’s Disease.". CEREBRAL CORTEX . 2020;

4 : 2372-2388

4.- Shahrzad Latifi, Simon Mitchell, R. Habibey, Fouzhan Hosseini, Elissa Donzis, Ana María Estrada-Sánchez, H. Rezaei Nejad, Michael Levine, Peyman Golshani, S. Thomas Carmichael "Neuronal network topology indicates distinct recovery processes after stroke". CEREBRAL CORTEX . 2020;

30 : 6363-6375

5.- Ana María Estrada-Sánchez, Courtney L. Blake, Scott J. Barton, Andrew G. Howe, George V. Rebec1 "Lack of mutant huntingtin in cortical efferents improves behavioral inflexibility and corticostriatal dynamics in Huntington’s disease mice". JOURNAL OF NEUROPHYSIOLOGY . 2019;

122 : 2621-2629

6.- Shin BC, Cepeda C, Estrada-Sánchez AM, Levine MS, Hodei L, Dai Y, Jung J, Ganguly A, Clark P, Devaskar SU. "Neural deletion of glucose transporter isoform 3 creates distinct postnatal and adult phenotypes.". JOURNAL OF NEUROSCIENCE . 2018;

38(44) : 9579-9599 Número de citas: 2

7.- Rangel-Barajas C*, Estrada-Sánchez AM*, Barton SJ, Leudke R, Rebec GV. * Primer autor. "Dysregulated corticostriatal activity in open-field behavior and the head-twitch response induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine. ". NEUROPHARMACOLOGY . 2017;

113 : 502-510

8.- Estrada-Sánchez AM, Burroughs CL, Cavaliere S, Barton SJ, Chen S, Yang XW, Rebec GV. "Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease". JOURNAL OF NEUROSCIENCE . 2015;

35 : 4440-4451 Número de citas: 29

9.- Estrada-Sánchez AM, Barton SJ, Burroughs CL, Doyle AR, and Rebec GV. "Dysregulated striatal neuronal processing and impaired motor behavior in mice lacking huntingtin interacting protein 14 (HIP14).". PLOS ONE . 2013;

8:12 : e84537 Número de citas: 5

10.- Guemez-Gamboa A*, Estrada-Sánchez AM*, Montiel T, Páramo B, Massieu L, Morán J. * Primer autor "Activation of NOX2 by the stimulation of ionotropic and metabotropic glutamate receptors contributes to glutamate neurotoxicity in vivo through the production of reactive oxygen species and calpain ac". JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY . 2011;

70 : 1020-1035 Número de citas: 51

11.- Estrada-Sánchez AM, Montiel T, Massieu L. "Glycolysis inhibition decreases the levels of glutamate transporters and enhances glutamate neurotoxicity in the R6/2 Huntington´s disease mice.". NEUROCHEMICAL RESEARCH . 2010;

35 : 1156-1163 Número de citas: 16

12.- Páramo B, Hernández-Fonseca K, Estrada-Sánchez AM, Jiménez N, Hernández-Cruz A, Massieu L. "Pathways involved in the generation of reactive oxygen and nitrogen species during glucose deprivation and its role on the death of cultured hippocampal neurons. ". NEUROSCIENCE . 2010;

167 : 1057-1069 Número de citas: 46

13.- Estrada-Sánchez AM, Montiel T, Segovia J, Massieu L. "Glutamate toxicity in the striatum of the R6/2 Huntington’s disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters. ". NEUROBIOLOGY OF DISEASE . 2009;

34 : 78-86 Número de citas: 79

14.- Orozco-Ibarra M, Estrada-Sánchez AM, Massieu L, Pedraza-Chaverrí. "Heme oxygenase-1 induction prevents neuronal damage triggered during mitochondrial inhibition: Role of CO and bilirubin". INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY . 2009;

41 : 1304-1314 Número de citas: 35

15.- Estrada-Sánchez AM, Mejía-Toiber J, Massieu L. "Excitotoxic neuronal death and the pathogenesis of Huntington’s disease (Review)". ARCHIVES OF MEDICAL RESEARCH . 2008;

39 : 265-276 Número de citas: 189

16.- Estrada-Sánchez AM, Camacho A, Montiel T, Massieu L. "Cerebellar granule neurons are more vulnerable to transient transport-mediated glutamate release than glutamate uptake blockade. Correlation with of excitatory amino acids levels". NEUROCHEMICAL RESEARCH . 2007;

32(3) : 423-432. Número de citas: 6

17.- Montiel T, Camacho A, Estrada-Sánchez AM, Massieu L. "Differential effects of the substrate inhibitor L-trans-pyrrolidine-2,4-dicarboxylate (PDC) and the non-substrate inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) of glutamate transporters on neur". NEUROSCIENCE . 2005;

133 : 667-678 Número de citas: 65

Publicaciones en otros índices internacionales

1.- Estrada-Sánchez AM, Rebec GV, Galvan L. " Editorial: New insight into Huntington's disease: From neuropathology to possible therapeutic targets". Frontiers in Neuroscience . 2023;

2.- Victor Manuel Ruiz-Rodríguez, Carlos Alberto Torres-González, Karina Monserrat Salas-Canedo, Nicole Quibey Pecina-Maza, Miguel Ernesto Martínez-Leija, Diana Patricia Portales-Pérez, Ana María Estrada-Sánchez "Dynamical changes in the expression of GABAergic and purinergic components occur during the polarization of THP-1 monocytes to proinflammatory macrophages". . 2023;

36 : 8

3.- Ares Orlando Cuellar-Santoyo, Victor Manuel Ruiz-Rodríguez, Teresa Belem Mares-Barbosa, Araceli Patrón-Soberano, Andrew G Howe, Diana Patricia Portales-Pérez, Amaya Miquelajáuregui Graf, Ana María Estrada-Sánchez "Revealing the contribution of astrocytes to glutamatergic neuronal transmission". Frontiers in Cellular Neuroscience . 2023;

16 : 15 Número de citas: 5

4.- Ruiz-Rodríguez VM, Turiján-Espinoza E, Guel-Pañola JA, García-Hernández MH, Zermeño-Nava JJ, López-López N, Bernal-Silva S, Layseca-Espinosa E, Fuentes-Pananá EM, Estrada-Sánchez AM, Portales-Pérez DP. "Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes.". Frontiers in Pharmacology . 2020;

11 : 576955

5.- Estrada-Sánchez AM, Castro D, Jang K, Portillo-Ortiz KM, Levine MS, Cepeda C. "Complete but not partial inhibition of glutamate transporters exacerbates cortical excitability in the R6/2 mouse model of Huntington’s disease.". CNS Neuroscience and Therapeutics . 2019;

25(4) : 509-518

6.- Leuchter MK, Donzis EJ, Cepeda C, Hunter AM, Estrada-Sánchez AM, Cook IA, Levine MS, Leuchter AF. "Quantitative electroencephalographic (qEEG) biomarkers in preclinical and human studies of Huntington’s disease: are they fit-for-purpose for treatment development? ". Frontiers in Neurology . 2017;

8 : 91 Número de citas: 6

7.- Hong SL, Estrada-Sánchez AM, Barton SJ, Rebec GV. (2016). "Early exposure to dynamic environments alters patterns of motor exploration throughout the lifespan.". Behavioral Brain Research . 2016;

302 : 81-87 Número de citas: 1

8.- Estrada-Sánchez AM, Scott J. Barton, Rebec GV. "Altered neuronal dynamics in the striatum of behaving huntingtin interacting protein 14 (HIP14) knockout mice". Brain Sciences . 2013;

3 : 1588-1596. Número de citas: 1

9.- Estrada-Sánchez AM, Rebec GV "Role of cerebral cortex in the neuropathology of Huntington's disease.". Frontiers in Neural Circuits . 2013;

7 : 19 Número de citas: 58

10.- Estrada-Sánchez AM, Rebec GV. "Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington´s disease: interactions between neurons and astrocytes". Basal Ganglia . 2012;

2 : 57-66 Número de citas: 60